Patent Assignment
Reel/Frame 037163/0890
Change of Address
Recorded: 2015-11-30
Pages: 3
Assignor
MITSUBISHI TANABE PHARMA CORPORATION
Executed: 2015-04-01
Assignee
MITSUBISHI TANABE PHARMA CORPORATION
3-2-10, DOSHO-MACHI, CHUO-KU, OSAKI-SHI, 541-8505, JAPAN
Covered Properties
(7)
Glucopyranoside Compound
Crystalline Form of 1-(B-D-Glucopyransoyl)-4-Methyl-3-[5-(4-Fluorophenyl)-2- Thienylmethyl]Benzene Hemihydrate
Glucopyranoside Compound
Crystalline Form of 1-(Beta-D-Glucopyranosyl)-4-Methyl-3-[5-(4-Fluorophenyl)-2-Thienylmethyl]Benzene Hemihydrate
Glucopyranoside Compound
Glucopyranoside Compound
Glucopyranoside Compound
Application:
14/299,470 →
Publication:
US 2014/0296506
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 28, 2005
From: NOMURA, SUMIHIRO; KAWANISHI, EIJI; UETA, KIICHIRO
To: TANABE SEIYAKU CO., LTD.
Reel/Frame 016731/0161 →
Change of Name
Oct 26, 2007
From: TANABE SEIYAKU CO., LTD.
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 020021/0001 →
Assignment of Assignor's Interest
Mar 3, 2008
From: NOMURA, SUMIHIRO; KAWANISHI, EIJI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 020588/0269 →
Corrective Assignment to Correct the Address of Assignee Previously Recorded on Reel 037163 Frame 0890. Assignor(S) Hereby Confirms the Correct Address Is as Follows: 3-2-10, Dosho-Machi, Chuo-Ku, Osaka-Shi, Osaka, 541-8505 Japan.
Dec 21, 2015
From: MITSUBISHI TANABE PHARMA CORPORATION
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 037354/0934 →
Change of Name
Mar 5, 2026
From: MITSUBISHI TANABE PHARMA CORPORATION
To: TANABE PHARMA CORPORATION
Reel/Frame 073977/0840 →